Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Khouri

Showing results (11-20 of 74) with videos related to

Pageof 8
Sort By:
Bone Marrow Transplantation|September 1, 1996
Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemiaG Rondón, S Giralt, Y Huh, et al.
Progress in Clinical and Biological Research|January 1, 1994
Graft failure and graft-vs-host disease after subtotal T-cell-depleted marrow transplantation: correlations with marrow hematopoietic and lymphoid subsetsD Przepiorka, Y O Huh, I Khouri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Use of octreotide in the symptomatic management of diarrhea induced by graft-versus-host disease in patients with hematologic malignanciesC Ippoliti, R Champlin, N Bugazia, et al.
Hematology/Oncology Clinics of North America|November 30, 1999
Allogeneic hematopoietic transplantation as adoptive immunotherapy. Induction of graft-versus-malignancy as primary therapyR Champlin, I Khouri, S Kornblau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1996
Impact of preexisting CNS involvement on the outcome of bone marrow transplantation in adult hematologic malignanciesK van Besien, D Przepiorka, R Mehra, et al.
British Journal of Haematology|December 1, 1992
Detection of minimal residual disease by polymerase chain reaction of bcr/abl transcripts in chronic myelogenous leukaemia following allogeneic bone marrow transplantationM Lee, I Khouri, R Champlin, et al.
Bone Marrow Transplantation|July 4, 2001
Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantationR Champlin, I Khouri, P Anderlini, et al.
British Journal of Haematology|November 25, 2000
Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapyR Champlin, I Khouri, A Shimoni, et al.
Bone Marrow Transplantation|September 1, 2000
High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplantM de Lima, K van Besien, J Gajewski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experienceA-M Tsimberidou, F J Giles, I Khouri, et al.
Pageof 8

Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
Bone Marrow Transplantation|September 1, 1996
Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemiaG Rondón, S Giralt, Y Huh, et al.
Progress in Clinical and Biological Research|January 1, 1994
Graft failure and graft-vs-host disease after subtotal T-cell-depleted marrow transplantation: correlations with marrow hematopoietic and lymphoid subsetsD Przepiorka, Y O Huh, I Khouri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Use of octreotide in the symptomatic management of diarrhea induced by graft-versus-host disease in patients with hematologic malignanciesC Ippoliti, R Champlin, N Bugazia, et al.
Hematology/Oncology Clinics of North America|November 30, 1999
Allogeneic hematopoietic transplantation as adoptive immunotherapy. Induction of graft-versus-malignancy as primary therapyR Champlin, I Khouri, S Kornblau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1996
Impact of preexisting CNS involvement on the outcome of bone marrow transplantation in adult hematologic malignanciesK van Besien, D Przepiorka, R Mehra, et al.
British Journal of Haematology|December 1, 1992
Detection of minimal residual disease by polymerase chain reaction of bcr/abl transcripts in chronic myelogenous leukaemia following allogeneic bone marrow transplantationM Lee, I Khouri, R Champlin, et al.
Bone Marrow Transplantation|July 4, 2001
Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantationR Champlin, I Khouri, P Anderlini, et al.
British Journal of Haematology|November 25, 2000
Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapyR Champlin, I Khouri, A Shimoni, et al.
Bone Marrow Transplantation|September 1, 2000
High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplantM de Lima, K van Besien, J Gajewski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experienceA-M Tsimberidou, F J Giles, I Khouri, et al.
Pageof 8